We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

58 hedge funds and large institutions have $85.6M invested in Astria Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

168% more capital invested

Capital invested by funds: $32M → $85.6M (+$53.7M)

0.95% more ownership

Funds ownership: 7.88% → 8.83% (+0.95%)

7% less call options, than puts

Call options by funds: $269K | Put options by funds: $290K

5% less funds holding

Funds holding: 61 → 58 (-3)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

48% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 23

Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
12
Reduced
23
Closed
20
Calls
$269K
Puts
$290K
Net Calls
-$21K
Net Calls Change
-$2.48M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$12.9M
2
PA
Perceptive Advisors
New York
+$12.5M
3
FFM
Fairmount Funds Management
Pennsylvania
+$8.74M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.68M
5
VA
VR Adviser
New York
+$7M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$3.74M
2
BlackRock
BlackRock
New York
-$2.13M
3
State Street
State Street
Massachusetts
-$1.06M
4
IC
Ikarian Capital
Texas
-$694K
5
Northern Trust
Northern Trust
Illinois
-$375K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$1K -$12.4K -956 -90%
Simplex Trading
52
Simplex Trading
Illinois
$1K -$11.9K -919 -92%
CG
53
Cutler Group
California
$1K – – –
KFI
54
Key Financial Inc
Pennsylvania
$1K – – –
Osaic Holdings
55
Osaic Holdings
Arizona
$1K – – –
Federated Hermes
56
Federated Hermes
Pennsylvania
$1K +$506 +39 New
SCM
57
Silverarc Capital Management
Massachusetts
$398 +$409K +31,463 New
SFM
58
Sphera Funds Management
Israel
– -$3.74M -215,667 Closed
BCM
59
Bridgeway Capital Management
Texas
– -$311K -17,933 Closed
N
60
Nuveen
North Carolina
– -$241K -13,933 Closed
Charles Schwab
61
Charles Schwab
California
– -$132K -7,602 Closed
VF
62
Virtu Financial
New York
– -$102K -5,855 Closed
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
– -$88K -5,088 Closed
Invesco
64
Invesco
Georgia
– -$88K -5,059 Closed
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
– -$61K -3,524 Closed
Connor, Clark & Lunn Investment Management (CC&L)
66
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$53K -3,042 Closed
CL
67
CSS LLC
Illinois
– -$48K -2,779 Closed
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
– -$35.4K -2,726 -99%
Ameriprise
69
Ameriprise
Minnesota
– -$44K -2,538 Closed
EGM
70
Engineers Gate Manager
New York
– -$38K -2,200 Closed
AIG
71
American International Group
New York
– -$34 -1,967 Closed
Deutsche Bank
72
Deutsche Bank
Germany
– -$34K -1,967 Closed
UBS Group
73
UBS Group
Switzerland
– -$25K -1,446 Closed
SWM
74
Spire Wealth Management
Virginia
– -$9K -500 Closed
Legal & General Group
75
Legal & General Group
United Kingdom
– -$6K -343 Closed
1 2
3
4

ATXS Hedge Fund Activity: Q2 2021 in Review

58 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q2 2021, worth a combined $85.6M — up 168% from $32M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ATXS and 17 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 12 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $12.9M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $3.74M sold.

  • 58 institutional investors held Astria Therapeutics (ATXS) as of Q2 2021, down from 61 in Q1 2021.
  • Funds reported $85.6M of Astria Therapeutics stock for Q2 2021, up 168% quarter-over-quarter.
  • 17 funds opened new Astria Therapeutics positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Astria Therapeutics buyer in Q2 2021 was RA Capital Management, an estimated $12.9M added.
  • The largest Astria Therapeutics seller in Q2 2021 was Sphera Funds Management, an estimated $3.74M sold.

Based on aggregated 13F filings for Q2 2021.